Table 5 Dosages and durations of sparfloxacin treatment during hospitalization
Sparfloxacin dosage
|
Resistance group
|
Intolerance group
|
Continuous proof group
|
| n |
n=16 |
n=12 |
n=2 |
| 400 mg·day1 |
10 |
4 |
|
| 300 mg·day1 |
5b |
4 |
2 |
| 200 mg·day1 |
1 |
3 |
|
| 100 mg·day1 |
|
1 |
|
| Mean; median (range) sparfloxacin therapy duration |
4; 3 (111 months) |
2.6; 2 (14 months) |
2.5, 3 months |
|
: 1 patient started with 400 mg, reduced to 200 mg at the end of therapy; b: 1 patient started with 200 mg, subsequently raised to 300 mg.
|